HomeNewsOpinionIf there is one toolkit the govt must pay attention to, it's the IMF’s vaccination plan

If there is one toolkit the govt must pay attention to, it's the IMF’s vaccination plan

The US alone has 80 million surplus doses available to donate as of April 2021 and this surplus stockpile will grow to around 350 million doses by the end of August 2021. That makes foreign minister S Jaishankar’s trip to the US of crucial importance in easing India’s vaccine shortage

Manas Chakravarty

May 24, 2021 / 09:53 IST

If there is one toolkit the govt must pay attention to, it's the IMF’s vaccination plan

Bharat Biotech, the Hyderabad-based COVID-19 vaccine maker, recently received approval from the Drugs Controller General of India to conduct clinical trials on children between the age of 2 and 18 (Representative image: PTI)

Watch Webinar

PRO Panorama

Moneycontrol Pro Panorama | Bets rise on rate cut in December as inflation tanks

Nov 13, 2025 / 02:54 PM IST

In November 13 edition of Moneycontrol Pro Panorama: GST cuts shine but food deflation rings alarm, Silver and Gold ETFs power up ...
Read Now

Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

View Offers

Unlock exclusive discounts